These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 10478647)
1. Quantification of delta-opioid receptors in human brain with N1'-([11C]methyl) naltrindole and positron emission tomography. Smith JS; Zubieta JK; Price JC; Flesher JE; Madar I; Lever JR; Kinter CM; Dannals RF; Frost JJ J Cereb Blood Flow Metab; 1999 Sep; 19(9):956-66. PubMed ID: 10478647 [TBL] [Abstract][Full Text] [Related]
2. Imaging of delta opioid receptors in human brain by N1'-([11C]methyl)naltrindole and PET. Madar I; Lever JR; Kinter CM; Scheffel U; Ravert HT; Musachio JL; Mathews WB; Dannals RF; Frost JJ Synapse; 1996 Sep; 24(1):19-28. PubMed ID: 9046073 [TBL] [Abstract][Full Text] [Related]
3. In vivo binding of N1'-([11C]methyl)naltrindole to delta-opioid receptors in mouse brain. Lever JR; Scheffel U; Kinter CM; Ravert HT; Dannals RF; Wagner HN; Frost JJ Eur J Pharmacol; 1992 Jun; 216(3):459-60. PubMed ID: 1330587 [TBL] [Abstract][Full Text] [Related]
4. Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects. Weerts EM; Kim YK; Wand GS; Dannals RF; Lee JS; Frost JJ; McCaul ME Neuropsychopharmacology; 2008 Feb; 33(3):653-65. PubMed ID: 17487229 [TBL] [Abstract][Full Text] [Related]
5. Imaging delta- and mu-opioid receptors by PET in lung carcinoma patients. Madar I; Bencherif B; Lever J; Heitmiller RF; Yang SC; Brock M; Brahmer J; Ravert H; Dannals R; Frost JJ J Nucl Med; 2007 Feb; 48(2):207-13. PubMed ID: 17268016 [TBL] [Abstract][Full Text] [Related]
6. N1'-fluoroethyl-naltrindole (BU97001) and N1'-fluoroethyl-(14-formylamino)-naltrindole (BU97018) potential delta-opioid receptor PET ligands. Tyacke RJ; Robinson ES; Schnabel R; Lewis JW; Husbands SM; Nutt DJ; Hudson AL Nucl Med Biol; 2002 May; 29(4):455-62. PubMed ID: 12031880 [TBL] [Abstract][Full Text] [Related]
7. Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography. Madar I; Lesser RP; Krauss G; Zubieta JK; Lever JR; Kinter CM; Ravert HT; Musachio JL; Mathews WB; Dannals RF; Frost JJ Ann Neurol; 1997 Mar; 41(3):358-67. PubMed ID: 9066357 [TBL] [Abstract][Full Text] [Related]
8. Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity. Fang L; Knapp RJ; Horvath R; Matsunaga TO; Haaseth RC; Hruby VJ; Porreca F; Yamamura HI J Pharmacol Exp Ther; 1994 Feb; 268(2):836-46. PubMed ID: 8113996 [TBL] [Abstract][Full Text] [Related]
9. PET imaging of human cardiac opioid receptors. Villemagne PS; Dannals RF; Ravert HT; Frost JJ Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1385-8. PubMed ID: 12271423 [TBL] [Abstract][Full Text] [Related]
10. Quantification of muscarinic cholinergic receptors with [11C]NMPB and positron emission tomography: method development and differentiation of tracer delivery from receptor binding. Zubieta JK; Koeppe RA; Mulholland GK; Kuhl DE; Frey KA J Cereb Blood Flow Metab; 1998 Jun; 18(6):619-31. PubMed ID: 9626186 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety. Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of radioiodinated naltrindole analogues: ligands for studies of delta opioid receptors. Kinter CM; Lever JR Nucl Med Biol; 1995 Jul; 22(5):599-606. PubMed ID: 7581169 [TBL] [Abstract][Full Text] [Related]
15. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice. Baker AK; Meert TF J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687 [TBL] [Abstract][Full Text] [Related]
16. An updated synthesis of N Kaur T; Brooks AF; Hockley BG; Torres J; Henderson BD; Scott PJH; Shao X J Labelled Comp Radiopharm; 2021 Apr; 64(4):187-193. PubMed ID: 33274468 [TBL] [Abstract][Full Text] [Related]
17. Kinetic analysis of transport and opioid receptor binding of [3H](-)-cyclofoxy in rat brain in vivo: implications for human studies. Sawada Y; Kawai R; McManaway M; Otsuki H; Rice KC; Patlak CS; Blasberg RG J Cereb Blood Flow Metab; 1991 Mar; 11(2):183-203. PubMed ID: 1847702 [TBL] [Abstract][Full Text] [Related]
19. Antagonism of delta(2)-opioid receptors by naltrindole-5'-isothiocyanate attenuates heroin self-administration but not antinociception in rats. Martin TJ; Kim SA; Cannon DG; Sizemore GM; Bian D; Porreca F; Smith JE J Pharmacol Exp Ther; 2000 Sep; 294(3):975-82. PubMed ID: 10945849 [TBL] [Abstract][Full Text] [Related]